Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that it has entered into its first international psilocybin supply agreement with Promises Innovative Recovery (“PIR”).
PIR is a globally-minded medical, research, and educational center focusing on preventative healthcare, precision medicine, and innovative treatments, including psychedelics-assisted psychotherapy and plant-based therapeutics. Pamela and Gary Roberts, founders of the Florida-based Social Impact Organization, provide expert substance abuse, addiction, and mental health services to treatment centers through its comprehensive and exceptional intensive outpatient protocol.
